HLN Stock — Haleon plc

Haleon plc (HLN)

Updated October 16, 2026.

HLN is a Stock. its distribution rate is 1.26%, its trailing-12-month yield is 1.93%. Dividend Vision Distribution Safety Score™ is 91/100 (Safe). Total return is 44.5% over the past 4.2 years, 66.8 points behind SPY at 111.3%.

Haleon plc is a consumer healthcare company that researches, develops, manufactures, and sells over-the-counter products across oral health, vitamins and supplements, respiratory care, pain relief, and digestive health, with well-known brands including Sensodyne, Centrum, Theraflu, Voltaren, and Advil across North America, Europe, and Asia Pacific. The company offers a modest current distribution rate paid semi-annually. Haleon appeals to income-focused investors seeking exposure to established consumer healthcare brands with regular dividend payments.

HLN performance versus SPY

Price and return data through 2026-10-16.

Total return is 44.5% over the past 4.2 years, 66.8 points behind SPY at 111.3%. Over the past year its total return — price change plus distributions reinvested — is 12.3%. Its deepest 1-year drawdown was 21.8%.

HLN key facts

Distribution Safety Score™

91 · Safe

Safety-Adjusted Yield

1.15%

Asset type

Stock

Asset class

Equity

Inception date

07/18/2022

Distribution rate

1.26%

Distribution frequency

Semi-Annual

Trailing yield

1.93%

Last close

$10.13 (as of 2026-10-16)

Market cap

$44,548,084,316

Average volume

17995338.0

Dividend

$0.064

Ex-dividend date

08/14/2026

Payment date

09/17/2026

Beta

0.283

Payout ratio

1.6%

P/E ratio

20.67

Forward P/E

15.6986

EPS

$0.49

How Dividend Vision calculates yield and returns

Distribution rate (1.26%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (1.93%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HLN risks and drawbacks

HLN's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are semi-annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 21.8%.

Who may consider HLN — and who may not

HLN may suit someone looking for a high Distribution Safety Score. It is a weaker fit for investors who need monthly cash flow (HLN pays semi-annual); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on HLN

• All tickers starting with H

Tagged: Pharmaceutical, Dividend.

Frequently asked questions